The mitogenic effect of bradykinin mediated by G protein-coupled B2Rs involving MEK/MAPK is observed in epithelial breast cancer cells [35], bovine tracheal smooth muscle cells [36], and also human renal carcinoma A498 cells [37]. Here, MAP2K7 is linked to breast carcinoma.